Production (Stage)
Tango Therapeutics, Inc.
TNGX
$1.84
-$0.025-1.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.86% | -29.15% | -14.15% | 32.61% | -23.25% |
| Total Depreciation and Amortization | 0.32% | -0.32% | -1.58% | 1.12% | 1.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.30% | 8.90% | -5.05% | 16.59% | 82.65% |
| Change in Net Operating Assets | -40.14% | 39.32% | -96.63% | 12.31% | -810.80% |
| Cash from Operations | -13.78% | -9.75% | -41.44% | 37.64% | -37.83% |
| Capital Expenditure | 58.87% | -7.83% | 64.06% | -64.10% | 13.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -41.27% | 59.66% | 151.06% | 218.27% | -132.30% |
| Cash from Investing | -41.23% | 59.84% | 156.48% | 213.35% | -133.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.79% | -59.66% | 83.22% | -96.95% | 2,416.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.79% | -59.66% | 83.22% | -96.95% | 2,829.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -167.75% | 935.52% | 116.48% | -57.90% | -177.41% |